Cencora COR
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Cencora (COR) Business Model and Operations Summary
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Key Insights
Cencora (COR) Core Market Data and Business Metrics
Latest Closing Price
$277.41Market Cap
$53.81 BillionPrice-Earnings Ratio
55.48Total Outstanding Shares
193.92 Million SharesTotal Employees
46,000Dividend
$0.55 Per Share QuarterlyIPO Date
April 4, 1995SIC Description
Wholesale-drugs, Proprietaries & Druggists' SundriesPrimary Exchange
New York Stock ExchangeHeadquarters
1 West First Avenue, Conshohocken, PA, 19428
Historical Stock Splits
If you bought 1 share of COR before December 29, 2005, you'd have 4 shares today.
| Execution Date | Split Amount |
|---|---|
| June 16, 2009 | 2-for-1 |
| December 29, 2005 | 2-for-1 |
Cash Flow Statement
October 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Operating Activities, Continuing | $-2.72 Billion |
| Net Cash Flow From Financing Activities, Continuing | $3.21 Billion |
| Net Cash Flow | $147.33 Million |
| Net Cash Flow From Investing Activities | $-343.04 Million |
| Net Cash Flow From Operating Activities | $-2.72 Billion |
| Net Cash Flow From Financing Activities | $3.21 Billion |
Income Statement
October 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Preferred Stock Dividends And Other Adjustments | $0 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
| Selling, General, and Administrative Expenses | $1.47 Billion |
| Nonoperating Income/Loss | $-57.87 Million |
| Income/Loss From Continuing Operations After Tax | $493.72 Million |
| Operating Expenses | $1.85 Billion |
Comprehensive Income
October 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Other Comprehensive Income/Loss | $-420.94 Million |
| Comprehensive Income/Loss | $72.78 Million |
| Comprehensive Income/Loss Attributable To Parent | $78.09 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $-5.31 Million |
Balance Sheet
October 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Noncurrent Assets | $19.07 Billion |
| Other Current Liabilities | $4.60 Billion |
| Accounts Payable | $49.91 Billion |
| Other Current Assets | $29.48 Billion |
| Assets | $69.05 Billion |
| Current Assets | $49.99 Billion |
Historical Dividends
Current dividend: $0.55 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Feb 5, 2025 | Mar 3, 2025 | Feb 14, 2025 | $0.55 | Quarterly |
| Nov 5, 2024 | Nov 29, 2024 | Nov 15, 2024 | $0.55 | Quarterly |
| Jul 31, 2024 | Aug 26, 2024 | Aug 9, 2024 | $0.51 | Quarterly |
| May 1, 2024 | May 24, 2024 | May 10, 2024 | $0.51 | Quarterly |
| Jan 31, 2024 | Feb 26, 2024 | Feb 9, 2024 | $0.51 | Quarterly |
| Nov 1, 2023 | Nov 27, 2023 | Nov 13, 2023 | $0.51 | Quarterly |